Four billion development at the Budapest site of 77 Elektronika Kft.

By: Trademagazin Date: 2025. 07. 16. 09:10

77 Elektronika Kft., a 100 percent domestically owned company that develops and manufactures medical diagnostic equipment, has reached another significant milestone. As part of the recently launched 4 billion forint investment, financed entirely from its own resources, the global company is moving its entire Budapest production capacity to one location and, in parallel, is implementing a significant technological modernization. The new unit will be established at the current Fehérvári út site, on a floor area of approximately 8,000 m² – more than two and a half times the previous production base.

77 Elektronika Kft., which exports to nearly 100 countries around the world, last embarked on a similar scale of development in 2017, when an independent Research, Development and Innovation Center was built on 1,400 m2, equipped with, among other things, 3D design software, modern electronic instrumentation and microscopes for miniature component design. However, the 4 billion forint investment that is now underway represents a completely new era for the company, which will be necessary to achieve its ambitious innovation goals.

“Our Dcont® blood glucose meter product line was the first in the world to enable laboratory-accurate blood glucose measurement during home self-monitoring, so we are working to surpass this and improve the measurement accuracy to ±7.5-8%. In addition, the strategic focus is on supplementing the UriSed® urine sediment testing system with new measurement technologies and developing a fast, innovative diagnostic test,”

– says Sándor Zettwitz, CEO and owner of 77 Elektronika Kft.

The new facility will house the company’s entire Budapest manufacturing portfolio, including the production of the latest, smaller-capacity, automated urine testing equipment. The modern, single-space design of the production hall enables flexible production as well as the rapid introduction and scaling of innovative technologies. The development is an integral part of the company’s long-term strategy, which focuses on the rapid and efficient industrial implementation of technological and product innovations.